Delivery Order SPE2DB25D3306-SPE2DB25FUBFN
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $29,524.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90 tablets of the diabetes medication Jardiance 10 mg. The contract is a Firm Fixed Price Delivery Order with a completion date of June 18, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $7,569.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug...
This federal contract award, valued at $32,589.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with a completion date of May 29, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $3,953.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a Firm Fixed Price delivery order contract with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $14,171.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a Firm Fixed Price Delivery Order contract with a performance period extending to May 15, 2025. The award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $7,964.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 2, 2024. The contract was not designated as a set-aside award. AmerisourceBergen holds a significant...
This federal contract award, valued at $4,167.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Jardiance 10 mg tablet, a diabetes treatment. It is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,633.29 delivery order contract is for the provision of Jardiance 25 mg tablets, a diabetes treatment medication. The contract is a firm fixed-price, non-set-aside award with a completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $14,475.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of March 3, 2025 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $10,735.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,013,835 units of the diabetes medication Jardiance 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...